BAFNA PHARMACEUTICALS
|
The Current P/S Ratio of BAFNA PHARMACEUTICALS is 1.69.
Share Price | ₹104.7 | Sep 01,2025 |
Market Cap | ₹248.0 Cr | |
Sales-TTM | ₹147.2 Cr | TTM-Standalone Results |
Price/Sales | 1.69x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of BAFNA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹248.0 Cr] as on Sep 01,2025
(/) Sales [ ₹147.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.69x ]
Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay '1.69 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAFNA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of BAFNA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of BAFNA PHARMACEUTICALS
PS Ratio Performance Analysis for BAFNA PHARMACEUTICALS
- BAFNA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.21x.
- BAFNA PHARMACEUTICALS 's operated at median p/e ratio of 1.7x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 4.56x.
- BAFNA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.05x.
How does BAFNA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
BAFNA PHARMACEUTICALS | 147.2 | 1.69 | 248.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 6.98 | 375,100.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.75 | 161,698.0 |
CIPLA LTD | 27,811.2 | 4.61 | 128,239.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.24 | 121,216.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.19 | 106,855.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.02 | 103,972.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.22 | 99,682.6 |
LUPIN LTD | 23,375.9 | 3.71 | 86,717.1 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.86 | 59,567.0 |
ABBOTT INDIA LTD | 6,589.9 | 10.34 | 68,151.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAFNA PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.69x |
Max industry PS | 16.75x |
Median industry PS | 4.61x |
Average industry PS | 6.51x |
You may also like the below Video Courses